Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Management of Steroid-Induced Nausea

Introduction to Management

  • The National Comprehensive Cancer Network recommends a combination approach using antiemetics targeting different mechanisms of action for patients experiencing nausea due to steroid use, with dopamine receptor antagonists such as metoclopramide or phenothiazines as first-line agents 1, 2

First-Line Management Options

  • For acute steroid-induced nausea, phenothiazines or dopamine receptor antagonists are effective first-line agents, according to the National Comprehensive Cancer Network 1, 2
  • If nausea persists despite as-needed dosing, administer antiemetics around the clock for 1 week, then adjust to as-needed dosing, as suggested by the National Comprehensive Cancer Network 1, 3
  • For patients with a history of steroid-induced nausea, prophylactic treatment with antiemetics is highly recommended before starting steroid therapy, based on guidelines from the National Comprehensive Cancer Network 2

Combination Therapy for Persistent Nausea

  • Rather than replacing one antiemetic with another, add medications with different mechanisms of action for synergistic effect, as recommended by the National Comprehensive Cancer Network 1, 2
  • Consider adding serotonin receptor antagonists which have lower rates of CNS side effects, according to the National Comprehensive Cancer Network 1, 3
  • Alternative agents to consider include scopolamine, olanzapine, and dronabinol, as suggested by the National Comprehensive Cancer Network 1, 4

Dosing Recommendations

  • Dopamine antagonists such as metoclopramide and prochlorperazine should be administered 3-4 times daily, with dosages of 20-30 mg and 10-20 mg orally, respectively, based on recommendations from the European Society for Medical Oncology 5, 6
  • Serotonin antagonists such as ondansetron and granisetron should be administered once daily, with dosages of 16-24 mg and 2 mg orally, respectively, as recommended by the European Society for Medical Oncology 5, 6

Special Considerations

  • Always assess for other potential causes of nausea when steroid-induced nausea persists, including constipation, CNS pathology, metabolic disorders, or other medications, as recommended by the National Comprehensive Cancer Network and the European Society for Medical Oncology 1, 7
  • If nausea persists for longer than a week despite antiemetic therapy, consider reassessing the underlying cause, adjusting the steroid dose, or switching to a different steroid formulation, according to the National Comprehensive Cancer Network 1

Monitoring and Follow-up

  • Monitor patients for common side effects of antiemetics, including sedation, extrapyramidal symptoms, and QT prolongation, as recommended by the National Comprehensive Cancer Network 4
  • If steroid-induced nausea significantly impacts quality of life and persists despite antiemetic therapy, consider consulting with specialists about alternative treatments or steroid-sparing approaches, based on guidelines from the National Comprehensive Cancer Network 1